HER2-low-positive breast cancer from four neoadjuvant clinical trials. Omar A, Arafat W. Lancet Oncol 2021;22:e426.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Omar A, Arafat W. HER2-low-positive breast cancer from four neoadjuvant clinical trials. Lancet Oncol 2021;22:e426.
PMID: 34592187